Efficacy and Safety Trial of Elobixibat in Patients With Chronic Idiopathic Constipation

NCT01833065 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

314

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated due to a distribution issue with the trial medication

Conditions

Chronic Idiopathic Constipation

Interventions

DRUG: Elobixibat 10 mg/day
DRUG: Elobixibat 5 mg/day
DRUG: Placebo

Sponsor

Ferring Pharmaceuticals